These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 14657818

  • 21. Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes.
    Karagüzel G, Satilmiş A, Akçurin S, Bircan I.
    Diabetes Res Clin Pract; 2006 Oct; 74(1):15-20. PubMed ID: 16621116
    [Abstract] [Full Text] [Related]

  • 22. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
    Garg SK, Gottlieb PA, Hisatomi ME, D'Souza A, Walker AJ, Izuora KE, Chase HP.
    Diabetes Res Clin Pract; 2004 Oct; 66(1):49-56. PubMed ID: 15364161
    [Abstract] [Full Text] [Related]

  • 23. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
    Hemmingsen B, Metzendorf MI, Richter B.
    Cochrane Database Syst Rev; 2021 Mar 04; 3(3):CD013498. PubMed ID: 33662147
    [Abstract] [Full Text] [Related]

  • 24. Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes.
    Home PD, Bolli GB, Mathieu C, Deerochanawong C, Landgraf W, Candelas C, Pilorget V, Dain MP, Riddle MC.
    Diabetes Obes Metab; 2015 Jan 04; 17(1):15-22. PubMed ID: 24957785
    [Abstract] [Full Text] [Related]

  • 25. [Switching of NPH insulin to glargine therapy in a cohort of diabetic patients: observational study].
    Maia FF, Melo FJ, Araújo IM, Araújo LR.
    Arq Bras Endocrinol Metabol; 2007 Apr 04; 51(3):426-30. PubMed ID: 17546241
    [Abstract] [Full Text] [Related]

  • 26. Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine.
    Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P, Santeusanio F.
    Nutr Metab Cardiovasc Dis; 2010 Sep 04; 20(7):519-26. PubMed ID: 19703761
    [Abstract] [Full Text] [Related]

  • 27. Insulin glargine improves hemoglobin A1c in children and adolescents with poorly controlled type 1 diabetes.
    Jackson A, Ternand C, Brunzell C, Kleinschmidt T, Dew D, Milla C, Moran A.
    Pediatr Diabetes; 2003 Jun 04; 4(2):64-9. PubMed ID: 14655261
    [Abstract] [Full Text] [Related]

  • 28. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.
    Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K, Pediatric Study Group of Insulin Glargine.
    Diabetes Care; 2001 Nov 04; 24(11):2005-6. PubMed ID: 11679478
    [No Abstract] [Full Text] [Related]

  • 29. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group.
    Roach P, Trautmann M, Arora V, Sun B, Anderson JH.
    Clin Ther; 1999 Mar 04; 21(3):523-34. PubMed ID: 10321421
    [Abstract] [Full Text] [Related]

  • 30. Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.
    Polonsky W, Traylor L, Gao L, Wei W, Ameer B, Stuhr A, Vlajnic A.
    J Diabetes Complications; 2017 Mar 04; 31(3):562-568. PubMed ID: 28040350
    [Abstract] [Full Text] [Related]

  • 31. The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargine.
    Buse JB, Wolffenbuttel BH, Herman WH, Hippler S, Martin SA, Jiang HH, Shenouda SK, Fahrbach JL.
    Diabetes Care; 2011 Feb 04; 34(2):249-55. PubMed ID: 21270182
    [Abstract] [Full Text] [Related]

  • 32. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump.
    Garg SK, Walker AJ, Hoff HK, D'Souza AO, Gottlieb PA, Chase HP.
    Diabetes Technol Ther; 2004 Feb 04; 6(1):9-15. PubMed ID: 15000764
    [Abstract] [Full Text] [Related]

  • 33. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
    Vora J, Cohen N, Evans M, Hockey A, Speight J, Whately-Smith C.
    Diabetes Obes Metab; 2015 Dec 04; 17(12):1133-41. PubMed ID: 26085028
    [Abstract] [Full Text] [Related]

  • 34. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
    Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T.
    Endocr J; 2007 Dec 04; 54(6):975-83. PubMed ID: 18000343
    [Abstract] [Full Text] [Related]

  • 35. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M, Tapanainen P, Veijola R.
    Pediatr Diabetes; 2008 Jun 04; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [Abstract] [Full Text] [Related]

  • 36. Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial.
    Rosenstock J, Fonseca V, Schinzel S, Dain MP, Mullins P, Riddle M.
    J Diabetes Complications; 2014 Jun 04; 28(5):742-9. PubMed ID: 24856612
    [Abstract] [Full Text] [Related]

  • 37. Daily insulin doses and injection frequencies of neutral protamine hagedorn (NPH) insulin, insulin detemir and insulin glargine in type 1 and type 2 diabetes: a multicenter analysis of 51 964 patients from the German/Austrian DPV-wiss database.
    Laubner K, Molz K, Kerner W, Karges W, Lang W, Dapp A, Schütt M, Best F, Seufert J, Holl RW.
    Diabetes Metab Res Rev; 2014 Jul 04; 30(5):395-404. PubMed ID: 24302583
    [Abstract] [Full Text] [Related]

  • 38. Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE observational study.
    Kurtoglu S, Atabek ME, Dizdarer C, Pirgon O, Isguven P, Emek S, PREDICTIVE Turkey Study Group.
    Pediatr Diabetes; 2009 Sep 04; 10(6):401-7. PubMed ID: 19220776
    [Abstract] [Full Text] [Related]

  • 39. Comparison of prandial AIR inhaled insulin alone to intensified insulin glargine alone and to AIR insulin plus intensified insulin glargine in patients with type 2 diabetes previously treated with once-daily insulin glargine.
    Rosenstock J, Eliaschewitz FG, Heilmann CR, Muchmore DB, Hayes RP, Belin RM.
    Diabetes Technol Ther; 2009 Sep 04; 11 Suppl 2():S63-73. PubMed ID: 19772451
    [Abstract] [Full Text] [Related]

  • 40. Switching from Neutral Protamine Hagedorn Insulin to Insulin Glargine 300 U/mL Improves Glycaemic Control and Reduces Hypoglycaemia Risk: Results of a Multicentre, Prospective, Observational Study.
    Wolnik B, Wiza D, Szczepanik T, Syta A, Klupa T.
    J Diabetes Res; 2020 Sep 04; 2020():8751348. PubMed ID: 32337298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.